AIXTRON (AIXA) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
27 Dec, 2025Executive summary
Q1 2025 order intake reached EUR 132 million, up 10% year-over-year, driven by strong Asian/Chinese demand despite weaker Western markets.
Revenues were EUR 113 million (or EUR 112.5 million), exceeding guidance but down 5% year-over-year; gross margin at 30% impacted by a EUR 5 million one-off personnel reduction.
EBIT was EUR 3.3 million (3% margin), down 67% year-over-year; net profit at EUR 5.1 million, down 53% year-over-year.
Confirmed full-year 2025 guidance despite market uncertainties and one-off personnel reduction costs.
Inventory reduction and improved working capital led to strong operating and free cash flow improvements.
Financial highlights
Q1 revenues reached EUR 112.5–113 million, down 5% year-over-year but above guidance.
Gross margin was 30%, adjusted to 35% excluding EUR 5 million one-off personnel costs.
EBIT for the quarter was EUR 3.3 million, mainly affected by lower gross profit from one-off expenses.
Operating cash flow improved to EUR 35.1 million, up over EUR 42 million from last year's negative EUR 7 million.
Free cash flow was EUR 29.8–30 million, a significant turnaround from negative EUR 33 million last year.
Cash balance increased to EUR 93.3 million from EUR 65 million at year-end 2024.
Outlook and guidance
Full-year 2025 revenue expected at EUR 530–600 million, about 10% below 2024 at midpoint.
Gross margin guidance at 41–42%, EBIT margin between 18–22%, both including EUR 5 million in one-off costs.
Q2 2025 revenues expected in the range of EUR 120–140 million.
Annualized savings from personnel reduction expected to improve margins by about 1 percentage point.
Visibility for FY 2025 remains low due to weak end-market demand, though structural growth drivers are intact.
Latest events from AIXTRON
- 2026 revenue is guided lower as optoelectronics and GaN power growth offset SiC decline.AIXA
Q4 202526 Feb 2026 - Stable 2024 revenues and robust SiC/GaN orders offset by lower profit and revised outlook.AIXA
Q2 20242 Feb 2026 - Q3 2024 order intake rose 21% with robust margins, but 2025 outlook remains cautious.AIXA
Q3 202417 Jan 2026 - 2024 saw record Q4 revenue, margin pressure, and China-driven SiC growth amid a cautious 2025 outlook.AIXA
Q4 202416 Dec 2025 - Strong Q2 revenue and margins support confirmed FY guidance despite lower order intake.AIXA
Q2 202516 Nov 2025 - Revenues and profit fell on market softness, but free cash flow and equity position strengthened.AIXA
Q3 20253 Nov 2025